Navigation Links
Oncology Care Quality Improvement Program Introduced by Bipartisan Coalition Dedicated to Better Cancer Care Nationwide
Date:6/19/2009

Legislators proud to introduce "Oncology Care Quality Improvement Program of 2009" to ensure that patients, doctors and families have the best health care tools available

Bill is endorsed by National Patient Advocate Foundation and US Oncology

WASHINGTON, June 19 /PRNewswire-USNewswire/ -- A bipartisan group of members from the U.S. House of Representatives introduced a bill late yesterday aimed at improving oncology care in the United States by refocusing efforts towards patient-centered cancer care delivery and studying the best methods to coordinate care and extend quality of life. The "Oncology Care Quality Improvement Program of 2009" will establish a voluntary pilot program to identify major areas of potential improvement to oncology care, including error reduction, increased patient education and care coordination, and expansion of end-of-life planning and counseling services.

This groundbreaking oncology legislation, led by U.S. Representative Joseph Crowley (NY-7), has 18 original cosponsors, including lead sponsors Reps. Mike Rogers (MI-08), Lois Capps (CA-23), Anna Eshoo (CA-14) and Paul Ryan (WI-01). The bill has been endorsed by National Patient Advocate Foundation (NPAF), US Oncology, Society of Gynecologic Oncologists (SGO), Association of Community Cancer Centers (ACCC) and UPMC Cancer Centers.

"Fighting cancer is a fight we must win," said Rep. Joseph Crowley (NY-7). "This innovative demonstration project will ensure that patients and doctors have the best tools and information at their disposal. By providing our health care providers with most-up-to date information on best practices, we will ensure cancer patients are given the best and most cost-effective care. I thank Rep. Rogers, Capps, Eshoo and Ryan and colleagues from both sides of the aisle for joining me in leading this fight for oncology patients, doctors and families. We are proud to have the endorse
'/>"/>

SOURCE U.S. House of Representatives
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine news :

1. US Oncology, Inc. Announces Issuance of $775 Million of Debt Securities
2. Varians RapidArc Radiotherapy Technology Enables Pioneering Cancer Treatments at Top Dutch Oncology Center
3. Oncology Program at Texas Health Dallas Receives Outstanding Achievement Award
4. US Oncology Launches Oncology-Specific EHR to the Open Market
5. Aptium Oncology Names New Chief Operating Officer
6. New Debt Securities of US Oncology, Inc.
7. Ortho Biotech Oncology Research & Development Announces Collaboration with National Cancer Institute to Develop Novel Cell Therapies to Treat Cancer
8. US Oncology, Inc. Announces $465 Million Senior Secured Notes Offering
9. Prometheus Presents Proprietary Oncology Diagnostic Platform at ASCO Annual Meeting
10. MedTrust Online Completes Second Round of Financing, Releases Next Generation Search Engine for Oncology Utilizing Dell eHealthcare Architecture Framework
11. Tool Shows Promise for Measuring Productivity of Mid-Level Oncology Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/16/2009)... 16 New Enterprise Associates, Inc. (NEA), ... that one of its portfolio companies, Acclarent, Inc., ... acquired by Ethicon, Inc., a Johnson & Johnson ... million (net of estimated cash on hand at ... to designing, developing and commercializing devices that address ...
(Date:12/16/2009)... Immucor, Inc. (Nasdaq: BLUD ), a ... blood transfusion industry, today announced that Paul D. Mintz, ... new independent director, effective January 1, 2010. ,, ... transfusion medicine for more than 30 years. He is ... University of Virginia School of Medicine. He also serves ...
(Date:12/16/2009)... For wounded U.S. servicemen and women recovering at Walter ... can be a particularly difficult time. Wounded soldiers ... ever on the healing power of connecting with family ... easier for Walter Reed patients as Verizon Wireless donated ... of minutes of holiday talk time for 2,500 recovering ...
(Date:12/16/2009)... 16 HealthSciences Institute will sponsor ... professionals, teams and organizations who serve individuals ... diseases in employer, health plan, medical home ... will offer free, noncommercial webinars on topics, ... prevention, management and care improvement. Each webinar ...
(Date:12/16/2009)... suggests it plays a role in reducing inflammation in ... A gene variant that plays a role in inflammation ... as well as adults who smoke. , Researchers also ... MMP12 gene had a lower risk of developing chronic ... on by smoking. , "The gene seems to be ...
Breaking Medicine News(10 mins):Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 3Health News:Immucor Appoints New Board Director 2Health News:Verizon Wireless Donates $10,000 in Long-Distance Calling Cards to Soldiers at Walter Reed Hospital 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 2Health News:New Learning Collaborative to Prepare Clinicians for Better Chronic Care 3Health News:Gene Variant Seems to Guard Against Asthma, COPD 2Health News:Gene Variant Seems to Guard Against Asthma, COPD 3
... , ... Washington, DC (PRWEB) December 8, 2008 -- SingaporeMedicine ... Borders: Singapore Second Edition. Following the success of the flagship ... Singapore Second Edition will be introduced at the Health Care Globalization ...
... reassurance their stress-related symptoms are treatable. , ... Dallas, ... of over 300 CEOs and businesspeople at the Warwick Melrose Hotel ... physician, Dr. Mark Anderson said with a smile, "you,re all going ...
... as ineffective in patients with chronic lymphocytic leukemia (CLL) ... II clinical trials, according to researchers at The Ohio ... and Solove Research Institute. , Together, the trials involved ... the drug flavopiridol (alvocidib). Responses were seen in approximately ...
... he was Army Chief of Staff and am proud to ... has dedicated his life to serving this nation.,He knows service ... , "The more than ... and, with record funding over the past eight years, they,deliver ...
... SAN FRANCISCO, Dec. 7 Results of the ... patients with relapsed or,refractory B-Cell non-Hodgkin,s lymphoma (NHL) ... the 50th Annual American Society of Hematology (ASH),Meeting. ... oral Syk,inhibitor is well-tolerated by these patients and ...
... FRANCISCO, December 7, 2008) Two studies examining the effects ... transplantation outcomes will be explored at a press conference taking ... 50th Annual Meeting of the American Society of Hematology in ... specialized technique for increasing the presence of stem cells in ...
Other Medicine News:Health News:Healthy Travel Media Launches Second Edition of Patients Beyond Borders Singapore Edition 2Health News:Healthy Travel Media Launches Second Edition of Patients Beyond Borders Singapore Edition 3Health News:Top Executives Tap Top Docs for Recession-Proof Relief 2Health News:Dismissed leukemia drug helps cll patients, studies show 2Health News:Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL 2Health News:Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL 3Health News:Phase 2 Results of Rigel's R788 Show Clinical Benefit in Diffuse Large B-Cell Lymphoma and CLL 4Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 2Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 3Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 4Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 5Health News:Research on the effects of stem cell source and patient age on transplantation outcomes 6
(Date:12/16/2009)... 16 HealthWarehouse.com, Inc. (OTC Bulletin Board: HEWA) ... secured $1 million in 12% per annum short term ... is an initial drawdown of $500,000, with accrued interest ... of $500,000 with accrued interest and principal repayable in ... Company becoming cashflow positive for any calendar month prior ...
(Date:12/16/2009)... December 16 Scientists at,deCODE genetics, Inc. ... the,discovery of a version of a common single-letter ... with a major impact on susceptibility to type ... is not only large, but unusual:,if an individual ... risk of,T2D by more than 30% compared to ...
(Date:12/16/2009)... Wis., Dec. 16 EuroPharma, Inc. ... for the use of super absorbency BCM-95® ... EuroPharma formulations. The exclusive distribution territory ... health food store channel and professional channel, ... and clinics. BCM-95® is a highly ...
Breaking Medicine Technology:HealthWarehouse.com, Inc. Secures $1 Million in Debt Financing 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 2deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 3deCODE Discovers a Major Risk Factor for Type 2 Diabetes Dependent on Parent of Origin 4EuroPharma Exclusive Distributor of BCM-95 and BosPure 2EuroPharma Exclusive Distributor of BCM-95 and BosPure 3Kansas Bioscience Authority Commits 2450 Million to Increase Venture Capital Accelerate Bioscience Business Growth 14408 1Kansas Bioscience Authority Commits 2450 Million to Increase Venture Capital Accelerate Bioscience Business Growth 14408 2Kansas Bioscience Authority Commits 2450 Million to Increase Venture Capital Accelerate Bioscience Business Growth 14408 3Award recognizes 30 years of anti smoking work 59213 1Award recognizes 30 years of anti smoking work 59213 2Developing enzymes to clean up pollution by explosives 10312 1
... Results presented at the Movement Disorder Society's 11th,International ... 08, 2007 /PRNewswire-FirstCall/ -- New,information on the use ... disease (PD) was reported this week at The,Movement ... approved by the FDA May 17, 2006, for ...
... 8, 2007 - AVANIR,Pharmaceuticals (NASDAQ:AVNR) today ... including efficacy, safety and improvements in,patient-centered ... (DPN) pain treated with the investigational ... and sigma-1 agonist. The data were ...
Other Medicine Technology:International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 2International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 3International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 4International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 5International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 6AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 2AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 3AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 4AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 5AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 6AVANIR Pharmaceuticals Presents Zenvia Phase III Data in Diabetic,Peripheral Neuropathic Pain at International Congress on,Neuropathic Pain 7
Non-sterile oncoseed seeds consists of a welded titanium capsule containing....
... Four 62 mirrors ... the angle with little ... flange is convenient for ... fissures. Anterior holding ring ...
Direct gonioscopy lens with magnification. The lens rests on the scleral flange creating a corneal vault and leaving the anterior chamber angle undisturbed. Three sizes available....
Shahinian lachrymal cannula, blunt tapered with side port....
Medicine Products: